QVT Financial’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,375,900
Closed -$40.8M 39
2023
Q4
$40.8M Hold
1,375,900
2.31% 4
2023
Q3
$21.8M Hold
1,375,900
1.23% 6
2023
Q2
$25.9M Hold
1,375,900
1.42% 5
2023
Q1
$5.28M Hold
1,375,900
0.26% 31
2022
Q4
$6.82M Hold
1,375,900
0.36% 24
2022
Q3
$6.58M Hold
1,375,900
0.46% 31
2022
Q2
$6.19M Hold
1,375,900
0.39% 34
2022
Q1
$6.55M Hold
1,375,900
0.28% 35
2021
Q4
$10.2M Hold
1,375,900
0.35% 30
2021
Q3
$7.8M Hold
1,375,900
0.58% 31
2021
Q2
$9.07M Hold
1,375,900
0.6% 27
2021
Q1
$11.1M Hold
1,375,900
0.78% 21
2020
Q4
$8.88M Hold
1,375,900
0.49% 25
2020
Q3
$4.95M Hold
1,375,900
0.6% 29
2020
Q2
$6.33M Hold
1,375,900
1.08% 27
2020
Q1
$4.69M Hold
1,375,900
1.09% 28
2019
Q4
$7.02M Hold
1,375,900
1.37% 25
2019
Q3
$3.33M Hold
1,375,900
0.68% 36
2019
Q2
$2.84M Hold
1,375,900
0.6% 33
2019
Q1
$3.44M Buy
+1,375,900
New +$5.96M 0.87% 30

Other funds holding IMGN

QVT Financial's IMGN Position: Q1 2024 in Review

QVT Financial sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,375,900 shares — an estimated $40.8M sold.

QVT Financial first reported a position in IMGN in Q1 2019 and held it in 20 quarters. The position peaked at $40.8M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • QVT Financial reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • QVT Financial sold 1,375,900 Immunogen Inc shares in Q1 2024, an estimated $40.8M.
  • QVT Financial first reported a position in Immunogen Inc in Q1 2019 and held it in 20 quarters.
  • QVT Financial's Immunogen Inc position peaked at $40.8M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on QVT Financial's 13F filing for Q1 2024, filed 15 May 2024.